Exane Derivatives’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $94K | Buy |
11,141
+5,267
| +90% | +$44.4K | 0.05% | 269 |
|
|
2022
Q1 | $79.9K | Buy |
5,874
+816
| +16% | +$11.1K | 0.02% | 498 |
|
|
2021
Q4 | $99.5K | Hold |
5,058
| – | – | 0.02% | 438 |
|
|
2021
Q3 | $162K | Buy |
5,058
+2,221
| +78% | +$71.3K | 0.04% | 429 |
|
|
2021
Q2 | $96.6K | Buy |
2,837
+871
| +44% | +$29.7K | 0.02% | 529 |
|
|
2021
Q1 | $73.8K | Sell |
1,966
-661
| -25% | -$24.8K | 0.02% | 457 |
|
|
2020
Q4 | $87.3K | Hold |
2,627
| – | – | 0.03% | 403 |
|
|
2020
Q3 | $96.3K | Sell |
2,627
-150
| -5% | -$5.5K | 0.03% | 286 |
|
|
2020
Q2 | $91.4K | Sell |
2,777
-325
| -10% | -$10.7K | 0.02% | 290 |
|
|
2020
Q1 | $80.1K | Buy |
+3,102
| New | +$80.1K | 0.02% | 290 |
|